Found 71 Enz. Inhib. hit(s) with all data for entry = 6398 TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 55.4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 370nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 430nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 620nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 750nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 780nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.11E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.21E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.37E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.57E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.19E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.66E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.72E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.85E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 3.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 3.20E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 3.44E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.31E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.34E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.48E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.50E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.54E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 4.76E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 5.90E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 6.61E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 6.64E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 6.81E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 7.43E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 7.80E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 8.06E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 8.12E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 9.24E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.13E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.17E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.33E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.35E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.37E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.76E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.77E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 1.81E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.15E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.34E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.37E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.37E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.64E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven
US Patent
Katholieke Universiteit Leuven
US Patent
Affinity DataIC50: 2.96E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
